NEWS AND RESOURCES

Stay up to date

Please visit this page for the latest announcements and events from ZielBio.
January 03, 2023 | Press Releases

ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics

READ MORE
December 23, 2022 | Press Releases

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

READ MORE
November 15, 2022 | Press Releases

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Cholangiocarcinoma

READ MORE
April 12, 2022 | Press Releases

ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131 in Cholangiocarcinoma at AACR Annual Meeting 2022

READ MORE